Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 6314   Home Print this page  Email this page Small font size Default font size Increase font size
Year : 1993  |  Volume : 11  |  Issue : 2  |  Page : 41-45

Clinical Evaluation Of Ketotifen In Bronchial Asthma

Correspondence Address:
R. C Bhasin

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Ketotifen, an orally active prophylactic agent was given to 30 asthmatic patients of mild to moderate severity. After eight weeks of therapy, 66.3% of patients showed an overall improvement in their respiratory symptoms and ventilatoty functions. Extrinsic asthma had better response (77.7%) as compared to intrinsic group (41.7%). Day time sedation was observed as the most common adverse effect of this drug.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded73    
    Comments [Add]    

Recommend this journal